论文部分内容阅读
Updated results from a phase Ⅲ trial of nivolumab(NIVO)combined with ipilimumab(IPI)in treatment-nai
【作 者】
:
【机 构】
:
Memorial Sloan Kettering Cancer Center,New York,NY
【出 处】
:
2016年临床肿瘤学新进展学术研讨会
【发表日期】
:
2016年5期
其他文献
Treatment-free remission(TFR)in patients(pts)with chronic myeloid leukemia in chronicphase(CML-CP)tr
会议
Randomized phase Ⅲ study on the effect of early intensification of rituximab in combination with 2-w
会议
A prospective,multicenter,randomized study of anti-CCR4 monoclonal antibody mogamulizumab(moga)vs in
会议
PILLAR-2:A randomized,double-blind,placebo-controlled,phase Ⅲ study of adjuvant everolimus(EVE)in pa
会议
Two years rituximab maintenance vs.observation after first-line treatment with bendamustine plus rit
会议
Upfront autologous stem cell transplantation(ASCT)versus novel agent-based therapy for multiple myel
会议
Three-year overall survival for patients with advanced melanoma treated with pembrolizumab in KEYNOT
会议